In a high-profile showdown Tuesday with Sen. Bernie Sanders’ Senate health committee, Novo Nordisk CEO Lars Fruergaard ...

Lawmakers are set to scrutinize the high cost of weight loss and diabetes drugs, which depending upon your insurance can ...

Jorgensen is set to testify before a Senate committee on Tuesday in a hearing focused on U.S. prices for its widely popular ...

Good evening! The last full-size Kmart store in the United States is closing. On a brighter note, the Philadelphia Phillies ...

Megyn Kelly criticized Oprah Winfrey's town hall event with Kamala Harris, claiming Winfrey is no longer the genuine figure ...

The CEO of Novo Nordisk will testify in the Senate HELP Committee tomorrow about the cost of popular diabetes and weight loss ...

As the Senate Committee on Health, Education, Labor and Pensions (HELP) gears up for a hearing tomorrow titled “Why Is Novo ...

Hearing on weight loss drug prices will feature CEO of Novo Nordisk and comes after threats to subpoena company executives.

It's the second lawsuit to be filed this year in Maine against insurance carriers that limit coverage of popular drugs like ...

Ozempic, for type 2 diabetes, has a U.S. list price of $969 a month, while Wegovy, the weight loss medication, has a list ...

Novo Nordisk CEO Lars Jergensen testified on the company's pricing for its diabetes and weight loss drugs, Ozempic and Wegovy, respectively. Public affairs events, congressional hearings, speeches, ...

Developed to treat diabetes, drugs like Ozempic now help fight obesity. Scientists newly honoured for working on them recall ...